Protein subunit interactions and structural integrity of amyloidogenic transthyretins: Evidence from electrospray mass spectrometry

Journal of Molecular Biology

Volumn 281, Issue 3, 1998, Pages 553-564

  Nettleton, Ewan J ^a   Sunde, Margaret ^a   Lai, Zhihong ^b   Kelly, Jeffery W ^b   Dobson, Christopher M ^a   Robinson, Carol V ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Amyloid; Hydrogen exchange; Mass spectrometry; Thyroxine; Transthyretin

Indexed keywords

AMYLOID; PREALBUMIN; PROTEIN SUBUNIT; THYROXINE; WATER;

ARTICLE; CONTROLLED STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE;

EID: 0032555738     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1998.1937     Document Type: Article

References (36)

1. Andrade C. A peculiar form of peripheral neurophaphy. Familial atypical generalised amyloidosis with special involvement of the peripheral nerves. Brain. 75:1952;408-427
2. Bai Y.W., Milne J.S., Mayne L., Englander S.W. Primary structure effects on peptide group hydrogen exchange. Proteins: Struct. Funct. Genet. 17:1993;75-86
3. Bai Y.W., Milne J.S., Mayne L., Englander S.W. Thermodynamic parameters from hydrogen exchange measurements. Methods Enzymol. 259:1995;344-356
4. Benson M.D. Familial amyloidotic polyneuropaphy. Trends Neurosci. 12:1989;88-92
5. Blake C.C.F., Geisow M.J., Oatley S.J., Rerat B., Rerat C. Structure of prealbumin secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å J. Mol. Biol. 121:1978;339-356
6. Booth D., Sunde M., Bellotti V., Robinson C.V., Hutchinson W.L., Fraser P.E., Hawkins P.N., Dobson C.M., Radford S.E., Blake C.C.F., Pepys M.B. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature. 385:1997;787-793
7. Chung E.W., Nettleton E.J., Morgan C.J., Groß M., Miranker A., Radford S.E., Dobson C.M., Robinson C.V. Hydrogen exchange properties of proteins in native and denatured states monitored by mass spectrometry and NMR. Protein Sci. 6:1997;1316-1324
8. Clarke J., Itzhaki L.S., Fersht A.R. Hydrogen exchange at equilibrium a short cut for analysing protein-folding pathways? Trends Biochem. Sci. 22:1997;284-287
9. Colon W., Kelly J.W. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry. 31:1992;8654-8660
10. Esnouf R.M. An extensively modified version of MolScript that includes greatly enhanced colouring capabilities. J. Mol. Graph. Model. 15:1997;132
11. Ganem B., Li Y.T., Henion J.D. Detection of non-covalent receptor-ligand complexes by mass spectrometry. J. Am. Chem. Soc. 113:1991;6294-6296
12. Gustavsson A., Jahr H., Tobiassen R., Jacobson D.R., Sletten K., Westermark P. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis. Lab. Invest. 73:1995;703-708
13. Jacobsen D.R., McFarlin D.E., Kane I., Buxbaum J.N. Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement. Human Genet. 89:1992;353-356
14. Kanai M., Raz A., Goodman D.S. Retinol binding protein - the transport protein for vitamin A in human plasma. J. Clin. Invest. 47:1968;2025-2044
15. Kelly J.W., Lansbury P.T. A chemical approach to elucidate the mechanism of transthyretin and B protein amyloid fibril formation. Amyloid: Int. J. Exp. Clin. Invest. 1:1994;186-205
16. Lai Z., Colon W., Kelly J.W. The acid mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry. 35:1996;6470-6482
17. Lai Z., McCulloch J., Lahuel A., Kelly J.W. Guanidine hydrochloride induced denaturation and refolding of transthyretin exhibits a marked hysteresis: equilibria with high kinetic barriers. Biochemistry. 36:1997;10230-10239
18. Lai Z., Lashuel H.A., Kelly J.W. Characterisation of the transthyretin acid denaturation pathway by analytical ultracentrifugation: implications for amyloid fibril formation. Biochemistry. 1998;. in the press
19. Light-Wahl K.J., Schwartz B.L., Smith R.D. Observation of non-covalent quaternary associations of proteins by electrospray ionization mass spectrometry. J. Am. Chem. Soc. 116:1994;5271-5278
20. Loo J.A., Edmonds C.G., Smith R.D. Tandem mass spectrometry of very large molecules 2. Dissociation of multiply charged proline-containing proteins from electrospray ionization. Anal. Chem. 65:1993;425-438
21. McCutchen S.L., Colon W., Kelly J.W. Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry. 32:1993;12119-12127
22. Merritt E., Murphy M. Raster 3D version 2.0: a program for photorealistic molecular graphics. Acta Crystallog. sect. D. 50:1994;869-873
23. Miroy G.J., Lai Z., Lashuel H., Peterson S.A., Strang C., Kelly J.W. Inhibiting transthyretin amyloid fibril formation via protein stabilization. Proc. Natl Acad. Sci. USA. 93:1996;15051-15056
24. Noy N., Slosberg E., Scarlata S. Interactions of retinol with binding proteins studies with retinol-binding protein and with transthyretin. Biochemistry. 14:1992;282-289
25. Pages R.A., Robbins J., Endelhock H. Binding of thyroxine and thyroxine analogs to human serum prealbumin. Biochemistry. 12:1973;2773-2779
26. Paz P.d.l., Burridge J., Oatley S., Blake C.C.F. Multiple modes of binding of thyroid hormones and iodothyronines to human plasma transthyretin. Beddell C. The Design of Drugs to Macromolecular Targets. 1992;120-172 John Wiley & Sons Ltd, New York
27. Raz A., Goodman D. The interaction of thyroxine with human plasma prealbumin and with the prealbumin retinol binding protein complex. J. Biol. Chem. 244:1969;3230-3237
28. Robinson C.V., Groß M., Eyles S.J., Ewbank J.J., Mayhew M., Hartl F.U., Dobson C.M., Radford S.E. Conformation of GroEL-bound alpha-lactalbumin probed by mass spectrometry. Nature. 372:1994;646-651
29. Robinson C.V., Chung E.W., Kragelund B.B., Knudsen J., Aplin R.T., Poulsen F.M., Dobson C.M. Probing the nature of non-covalent interactions by mass spectrometry. A study of protein-CoA ligand binding and assembly. J. Am. Chem. Soc. 118:1996;8646-8653
30. Savaiva M. Transthyretin mutation in health and disease. Human Mutat. 5:1995;191-196
31. Serpell L., Blake C.C.F. Frequency analysis and structural correlation of FAP mutations in transthyretin. Amyloid and Amyloidoses. 1994;447-450 Parthenon Publishing Group Inc, New York
32. Serpell L., Goldstein G., Dacklin I., Lundgren E., Blake C.C.F. The "edge strand" hypothesis prediction and test of a mutational "hot spot" on the transthyretin molecule associated with FAP amyloidogenesis. Amyloid: Int. J. Exp. Clin. Invest. 3:1996;75-85
33. Terry C.J., Damas A.M., Oliviera P., Savaria M.J.M., Alves A.L., Costa P.P., Matias P.M., Sakaki Y., Blake C.C.F. Structure of the Met30 variant of transthyretin and its amyloidogenic implications. EMBO J. 12:1993;735-741
34. Westermark P., Sletten K., Johansson B., Cornwell G.G. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl Acad. Sci. USA. 87:1990;2843-2845
35. Wetzel R. For protein misassembly its the I decade. Cell. 86:1996;699-702
36. Zhang H., Stockel J., Mehlhorn I., Groth D., Baldwin M.A., Prusiner S.B., James T.L., Cohen F.E. Physical studies of conformational plasticity in a recombinant prion protein. Biochemistry. 36:1997;3543-3553